1FOKKENS W, LUND V, MULLOL J, et al. European Posi- tion Paper on Rhinosinusitis and Nasal Polyps 2007 [ J ]. Rhinolagy, 2007,45 ( 20 ) : 1 - 139.
2SLAVIN R G, SPECTOR S L, BERNSTEIN I L, et al. The diagnosis and management of sinusitis:a practice parameter update [ J ]. J Allergy Clin Immunol, 2005,1 ! 6 ( 6 ) : 13-47.
3SCHAPPERT S M, BURT C W. Ambulatory care visits to phy-sician offices, hospital outpatient departments, and emergency departments : United States, 2001-2002. NationalCenter for Health Statistics [ J ]. Vital Health Star, 2006,13 (159) :1-66.
4ZALMANOVICI A, YAPHE J. Steroids for acute sinusitis [ J ]. Cochrane Database Syst Rev, 2007,18 ( 2 ) :49-51.
5MARPLE B F, BRUNTON S, FERGUSON B J. Acute bac- terial rhinosinusitis : a review [ J]. Otolaryngol Head Neck of- U. S. treatment guidelines Surg, 2006, 135 ( 3 ) : 341 -348.
6WALD E R. Sinusitis acute otitis media and acute bacterial sinusitis [ J ]. Clin Infec Dis, 2011,52 ( 4 ) :277-283.
7VALERIE J, LUND M D. Therapeutic targets in rhinosin- usitis: infection or inflammation? [ J ]. Medscape J Med, 2008,10(4) :105.
8MELTZER E O, BACHERT C, STAUDINGER H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo [ J ]. J Allergy Clin Immunol, 2005,116 ( 6 ) : 1289-1295.
9SMALL C B, BACHERT C, LUND V J, et al. Judicious antibiotic use and intranasal eorticosteroids in acute rhinosinusitis [ J ]. Am J Med, 2007,120 ( 4 ) :289-294.
10MELTZER E O, ORGEL H A, BACKHAUS J W, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis[ J]. J Allergy Clin Immunol, 1993,92 (6) :812-823.
2MALTAIS F, OSTINELLI J, BOURBEAU J, et al. Compa- rison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronicobstructive pulmonary disease:a randomized controlled trial [J]. Am J Respirb Grit Care Med, 2002, 165(5):698- 700.
3ZHENG J P, KANG J, HUEN S G , et al. Effect of cabo- cisteine on acute excerbation of chronic obstractive pulmonary disease ( peace study ) : a randomised placebo- cotrolled[J]. Lancet ,2008,371 (11) :2013-2018.
4HURST J R, WEDZICHA J A. Chronic obstructive pulm- onary disease: the clinical management of an acute exacerbation[J]. Postgrad Med J, 2004, 80 ( 3 ) : 497 - 500.
5SETHI S. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease [J]. Semin Respir Crit Care Med, 2005, 26(2):192-194.
6FILE T M J R. New insights in the treatment by levofloxacin [J]. Chemot Herapy, 2004, 50(1):22-30.
7SHAH P M, MAESEN F P, DOLMANN A, et al. Levo- floxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis : results of a randomized, double-blind study[J]. J Antimicrob Chemother, 1999, 43 (3) :529-530.
8WILSON R, ALLEGRA L, HUCHON G, et al. Short term and long term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis [J]. Chest, 2004, 125 (8) : 953-955.
9LISTER P D, WOLTER D J. Levofloxacin-imipenem com- bination prevents the emergence of resistance among clinical isolates of pseudomonas aeruginosa [J]. Clin Infect Dis,2005, 40(1) :105-110.
10WILKINSON T M, DONALDSON G C, HURST J R, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2004, 169(10) :1298-1300.
1Macri GF, Greco A, Marinelli C, et al. Evidence and role of autoanti- bodies in chronic rhinosinusitis with nasal polyps [ J ]. Int J Immuno- pathol Pharmacol, 2014,27 (2) : 155 - 161.
2Drinka P. Preventing aspirationin the nursing home:the role of biofil- mand data from the ICU[ J]. J Am Med Dir Assoe, 2010,11 ( 1 ) :70 - 77.
